IntegraGen SA (EPA:ALINT)
0.0274
-0.0140 (-33.82%)
Oct 9, 2026, 5:24 PM CET
IntegraGen Market Cap
IntegraGen has a market cap or net worth of €180.69 thousand as of October 9, 2026. It is the 50,865th most valuable company in the world and the 686th biggest in France. Its market cap has decreased by 81.81% in one year.
Market Cap
180.69K
Enterprise Value
-629.92K
Revenue
5.02M
Global Rank
Country Rank
#686 France
PE Ratio
n/a
ChartMarket Cap Chart
Since June 18, 2010, IntegraGen's market cap has decreased from 34.24M to 180.69K, a decrease of -99.47%. That is a compound annual growth rate of -27.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 180.69K | -79.48% |
| Dec 31, 2025 | 880.55K | -76.46% |
| Dec 31, 2024 | 3.74M | -36.97% |
| Dec 29, 2023 | 5.93M | -25.72% |
| Dec 30, 2022 | 7.99M | 8.73% |
| Dec 31, 2021 | 7.35M | -46.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biophytis | 17.23M |
| Aton | 12.26M |
| TME Pharma | 12.14M |
| Aelis Farma | 11.29M |
| Advicenne | 9.14M |
| NFL Biosciences | 8.50M |
| Poxel | 7.17M |
| Oncodesign Precision Medicine Société anonyme | 6.34M |